Re: RVX Long Covid Trial
in response to
by
posted on
May 30, 2023 09:19AM
RVXOT the June 2022 (Annual General Meeting) presentation (Slide 9) states the following for BETonMACE2:
Approximate Cost $80MM
Resverlogix Cost $40MM +
The slide does not mention Shenzhen Hepalink's participation in BOM2.
Koo